Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00427427
Recruitment Status : Terminated (lack of accrual)
First Posted : January 29, 2007
Last Update Posted : August 1, 2016
Information provided by:
Jonsson Comprehensive Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Actual Study Completion Date : October 2007